Article info

Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial

Authors

  1. Correspondence to Andrew Davies, Gastrointestinal Medicine and Surgery, Guy's and St Thomas' Hospitals NHS Trust, London SE1 7EH, UK; Andrew.Davies1{at}gstt.nhs.uk
View Full Text

Citation

Zylstra J, Whyte GP, Beckmann K, et al
Exercise prehabilitation during neoadjuvant chemotherapy may enhance tumour regression in oesophageal cancer: results from a prospective non-randomised trial

Publication history

  • Accepted December 6, 2021
  • First published February 1, 2022.
Online issue publication 
March 17, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.